Risk factor
Low price volatility
Profitability factor
Weak growth
About
HBM Healthcare Investments AG specializes in fund of funds and direct investments in middle market and mature companies. The fund prefers to invest in start up, early stage, mid stage, mid venture, late venture, and late stage private companies, unlisted emerging companies, small cap public companies, buyouts, growth capital, and private investment in public equities...
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on E
Target Price
The average target price of HBMN.SW is 257 and suggests 8% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation
Buy
Sell